Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Jun-23 6:12 PM View:  | Avalo Therapeutics, Inc. (CERC) | 27-Jun-23 | Sale | 937,404 | $0.52 | $486,888.00 | (55%) 1.7M to 765.83K | |
| 28-Jun-23 6:12 PM View: | Avalo Therapeutics, Inc. (CERC) | 26-Jun-23 | Sale | 2,746,140 | $0.61 | $1,682,010.00 | (62%) 4.45M to 1.7M | |
| 09-Feb-23 4:32 PM View: | Avalo Therapeutics, Inc. (CERC) | 07-Feb-23 | Purchase | 450,000 | -- | -- | 11% 4.0M to 4.45M | |
| 09-Feb-23 4:32 PM View: | Avalo Therapeutics, Inc. (CERC) | 03-Feb-23 | Acquisition (small) | 334 | $3.95 | $1,319.30 | < 1% 4.0M to 4.0M | |
| 14-Mar-22 5:38 PM View: | Avalo Therapeutics, Inc. (CERC) | 14-Mar-22 | Purchase | 100,000 | $0.65 | $64,940.00 | < 1% 47.89M to 47.99M | |
| 14-Mar-22 5:38 PM View: | Avalo Therapeutics, Inc. (CERC) | 11-Mar-22 | Purchase | 100,000 | $0.69 | $68,780.00 | < 1% 47.79M to 47.89M | |
| 14-Mar-22 5:38 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Mar-22 | Private Purchase | 26,000 | $0.70 | $18,226.00 | < 1% 47.76M to 47.79M | |
| 07-Mar-22 6:09 PM View: | Avalo Therapeutics, Inc. (CERC) | 07-Mar-22 | Purchase | 325,000 | $0.66 | $213,330.00 | < 1% 47.44M to 47.76M | |
| 07-Mar-22 6:09 PM View: | Avalo Therapeutics, Inc. (CERC) | 04-Mar-22 | Purchase | 135,000 | $0.70 | $95,107.50 | < 1% 47.3M to 47.44M | |
| 07-Mar-22 6:09 PM View: | Avalo Therapeutics, Inc. (CERC) | 03-Mar-22 | Private Purchase | 50,000 | $0.71 | $35,695.00 | < 1% 47.25M to 47.3M | |
| 28-Feb-22 5:53 PM View: | Avalo Therapeutics, Inc. (CERC) | 25-Feb-22 | Purchase | 40,000 | $0.79 | $31,716.00 | < 1% 47.21M to 47.25M | |
| 28-Feb-22 5:53 PM View: | Avalo Therapeutics, Inc. (CERC) | 24-Feb-22 | Private Purchase | 100,000 | $0.80 | $80,090.00 | < 1% 47.11M to 47.21M | |
| 22-Feb-22 6:37 PM View: | Avalo Therapeutics, Inc. (CERC) | 22-Feb-22 | Purchase | 83,000 | $0.77 | $64,076.00 | < 1% 47.03M to 47.11M | |
| 22-Feb-22 6:37 PM View: | Avalo Therapeutics, Inc. (CERC) | 18-Feb-22 | Purchase | 55,000 | $0.82 | $45,237.50 | < 1% 46.97M to 47.03M | |
| 22-Feb-22 6:37 PM View: | Avalo Therapeutics, Inc. (CERC) | 17-Feb-22 | Private Purchase | 150,000 | $0.81 | $122,250.00 | < 1% 46.82M to 46.97M | |
| 20-Jan-22 6:14 PM View: | Avalo Therapeutics, Inc. (CERC) | 20-Jan-22 | Purchase | 12,000 | $0.85 | $10,208.40 | < 1% 46.81M to 46.82M | |
| 20-Jan-22 6:14 PM View: | Avalo Therapeutics, Inc. (CERC) | 19-Jan-22 | Purchase | 93,700 | $0.88 | $82,053.10 | < 1% 46.72M to 46.81M | |
| 20-Jan-22 6:14 PM View: | Avalo Therapeutics, Inc. (CERC) | 18-Jan-22 | Private Purchase | 206,300 | $0.88 | $182,225.00 | < 1% 46.51M to 46.72M | |
| 14-Jan-22 5:49 PM View: | Avalo Therapeutics, Inc. (CERC) | 14-Jan-22 | Purchase | 85,000 | $0.93 | $78,973.50 | < 1% 46.43M to 46.51M | |
| 14-Jan-22 5:49 PM View: | Avalo Therapeutics, Inc. (CERC) | 13-Jan-22 | Purchase | 312,700 | $1.00 | $314,013.00 | < 1% 46.11M to 46.43M | |
| 14-Jan-22 5:49 PM View: | Avalo Therapeutics, Inc. (CERC) | 12-Jan-22 | Private Purchase | 57,300 | $1.04 | $59,781.10 | < 1% 46.06M to 46.11M | |
| 11-Jan-22 6:18 PM View: | Avalo Therapeutics, Inc. (CERC) | 11-Jan-22 | Purchase | 16,003 | $0.96 | $15,342.10 | < 1% 46.04M to 46.06M | |
| 11-Jan-22 6:18 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Jan-22 | Purchase | 491,097 | $0.99 | $484,615.00 | 1% 45.55M to 46.04M | |
| 11-Jan-22 6:18 PM View: | Avalo Therapeutics, Inc. (CERC) | 07-Jan-22 | Private Purchase | 137,900 | $1.04 | $142,975.00 | < 1% 45.41M to 45.55M | |
| 17-Sep-21 2:25 PM View: | Avalo Therapeutics, Inc. (CERC) | 17-Sep-21 | Private Purchase | 5,454,540 | $2.20 | $12,000,000.00 | 14% 39.96M to 45.41M | |
| 17-Sep-21 2:25 PM View: | Avalo Therapeutics, Inc. (CERC) | 16-Sep-21 | Private Purchase | 150,000 | $2.28 | $341,955.00 | < 1% 39.81M to 39.96M | |
| 17-Sep-21 2:25 PM View: | Avalo Therapeutics, Inc. (CERC) | 15-Sep-21 | Private Purchase | 95,455 | $2.26 | $215,948.00 | < 1% 39.71M to 39.81M | |
| 06-Aug-21 3:15 PM View: | Avalo Therapeutics, Inc. (CERC) | 06-Aug-21 | Market Purchase | 25,000 | $2.83 | $70,630.00 | < 1% 39.64M to 39.66M | 5% |
| 06-Aug-21 3:15 PM View: | Avalo Therapeutics, Inc. (CERC) | 05-Aug-21 | Market Purchase | 25,000 | $2.77 | $69,295.00 | < 1% 39.61M to 39.64M | 8% |
| 06-Aug-21 3:15 PM View: | Avalo Therapeutics, Inc. (CERC) | 04-Aug-21 | Market Purchase | 100,000 | $2.69 | $268,590.00 | < 1% 39.51M to 39.61M | 11% |
| 03-Aug-21 10:00 PM View: | Kiora Pharmaceuticals Inc (EYEG) | 02-Aug-21 | Market Sale | 192,775 | $2.40 | $463,046.00 | (20%) 977.77K to 785.0K | 18% |
| 03-Aug-21 10:00 PM View: | Kiora Pharmaceuticals Inc (EYEG) | 30-Jul-21 | Market Sale | 68,188 | $2.69 | $183,562.00 | (7%) 1.05M to 977.77K | 27% |
| 29-Jul-21 7:59 PM View: | Kiora Pharmaceuticals Inc (EYEG) | 29-Jul-21 | Market Sale | 400,000 | $3.00 | $1,200,000.00 | (28%) 1.45M to 1.05M | 34% |
| 29-Jul-21 7:59 PM View: | Kiora Pharmaceuticals Inc (EYEG) | 28-Jul-21 | Market Sale | 375,443 | $3.28 | $1,232,620.00 | (21%) 1.82M to 1.45M | 40% |
| 29-Jul-21 7:59 PM View: | Kiora Pharmaceuticals Inc (EYEG) | 27-Jul-21 | Conversion | 852,500 | $4.80 | $4,092,000.00 | 25% 3.35M to 4.2M | (59%) |
| 29-Jul-21 7:59 PM View: | Kiora Pharmaceuticals Inc (EYEG) | 27-Jul-21 | Market Sale | 2,377,700 | $5.09 | $12,113,600.00 | (57%) 4.2M to 1.82M | 61% |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | 1,479,710 | -- | -- | 20% 7.32M to 8.8M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | -- | -- | -- | 0% 8.8M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | 1,479,710 | -- | -- | 17% 8.8M to 10.28M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | -- | -- | -- | 0% 10.28M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | 676,440 | -- | -- | 7% 10.28M to 10.95M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | -- | -- | -- | 0% 10.95M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | 676,440 | -- | -- | 6% 10.95M to 11.63M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | -- | -- | -- | 0% 11.63M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | 2,254,800 | -- | -- | 19% 11.63M to 13.88M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | -- | -- | -- | 0% 13.88M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | 563,700 | -- | -- | 4% 13.88M to 14.45M | |
| 29-Jun-21 9:44 PM View: | Reshape Lifesciences Inc. (OBLN) | 28-Jun-21 | Exercise (in-the money or at-the-money) | -- | -- | -- | 0% 14.45M | |
| 22-Jun-21 8:58 AM View: | Reshape Lifesciences Inc. (OBLN) | 18-Jun-21 | Market Sale | 685,583 | $5.48 | $3,756,990.00 | (76%) 897.33K to 211.75K | |
| 22-Jun-21 8:58 AM View: | Reshape Lifesciences Inc. (OBLN) | 18-Jun-21 | Sale | -- | -- | -- | 0% 211.75K |